This deletion, therefore, results in overexpression of the anti-oncogenic GRIK2, apoptosis and decreased proliferation and migration while also revealing a possible tumorigenic role of SETDB1 in osteosarcomas [123]. The gene discussed is GRIK2; the disease is osteosarcoma.